Health
Personalised cancer vaccine tested in early ovarian cancer trial
A phase 1 trial is testing personalised neoantigen-targeting vaccines for ovarian cancer.
Early-stage trials primarily assess safety and appropriate dosing. The approach is experimental and is not yet established as a standard treatment.